4Goldstein AB, Castile RG, Davis SD, et al. Bronchodilator responsiveness in normal infants and young children [ J 1. Am J Respir Crit Care Med, 2001, 164(3) : 447-454.
5Cazzola M, Matera MG. Novel long-acting bronchodilators for COPD and asthma [ J l. Br J Pharmacol, 2008, 155 (3): 291-299.
6Beeh KM, Derom E, Kanniess F, et al. Indaeaterol, a novel inhaled beta 2-agonist, provides sustained 24 h bronchodilation in asthma [J~. Eur Respir J, 2007, 29(5) : 871-878.
7Cates C J, Cates MJ. Regular treatment with salmeterol for chronic asthma: serious adverse events [ J ]. Cochrane Database Sys! Rev, 2008, 16(3): No: CD006363.
8Bateman ED, Bousquet J, Busse WW, et al. Stability of asthma control with regular treatment : an analysis of the Gaining Optimal Asthma ontrol (GOAL) study [ J]. Allergy, 2008, 63 (7) : 932- 938.
9Elkout H, McLay JS, Simpson CR, et al. A retrospective obser- vational study comparing rescue medication use in children on combined versus separate long-acting { beta t -agonists and cortico- steroids [J]. Arch Dis Child, 2010, 95(10) : 817-821.
10Moore PE. Exploration of the beta 2-adrenergic receptor regulatory regions: the next step in the holy grail of asthma pharmacogenet- ics research [ J]. Am J Physiol Lung Cell Mol Physiol, 2008, 294(2) : 190-195.
